NextGen Omics 2025

Oxford Nanopore are sponsors, exhibiting and presenting at this event.

Join leaders, experts and researchers at the most scientifically engaging event in London delivering breakthrough research, technologies and therapeutic applications across Next Generation Sequencing, Clinical Diagnostics, Single Cell & Spatial Analysis, Synthetic Biology, Digital PCR and Liquid Biopsies.

For answers with impact, Switch ON. Analyze genomic, epigenomic, and transcriptomic data to reveal new functions and causes of disease—all from a single platform.

Location: Conference Room 1 Bourgogne: Clinical Genomics

Date: Thursday 13th November

Time: 14:55 — 15:20 GMT

Speaker: Rachel Hipkin

Rachel will discuss the following topics in conjunction with customer case studies:​

• Obtaining genomic and epigenomic data from a single dataset to directly analyse native DNA to uncover genomic variants alongside methylation status in a single nanopore sequencing run. ​

• Going beyond gene-level analysis for transcriptomic sequencing to gain isoform-level expression information with full- length transcript sequencing and identify fusions with ease using native RNA or cDNA sequencing.​

Resolving the mechanisms underpinning human diseases is vital to understand disease phenotypes, identify novel biomarkers, and enable drug discovery. Multiomic approaches — spanning genomics, epigenetics, bulk and single-cell transcriptomics, and proteomics — are crucial to this, providing data to help unravel complex pathways. In disease research, tissue samples are invaluable and scarce resources; maximising the information obtained from these samples is essential. However, legacy multiomic methods require the use of multiple platforms and often involve complex workflows, lengthy turnaround times, and considerable costs. Even when combining data from multiple traditional technologies, valuable information is missed from precious research samples, leaving important biological mechanisms unresolved.In this talk, Rachel Hipkin, Oxford Nanopore Technologies, will showcase how multiomic Oxford Nanopore sequencing can accelerate your research, from rare disease to oncology — all on a single platform with flexible and fast nanopore sequencing workflows to provide informative results in meaningful turnaround times.​

Expanding Spatial and Single Cell Transcriptomics Discovery with Full-Length Transcript Sequencing

Location: Conference Room 3 - Bourg: Single Cell & Spatial Analysis: Proteomics, Metabolomics & Epigenomics

Date: Friday 14th November

Time: 09:55 — 10:20 GMT

Discover how combining single-cell and spatial transcriptomics with Oxford Nanopore’s long-read sequencing unlocks a new level of biological insight. This talk highlights how full-length transcript data reveals isoforms, fusions, and SNPs missed by short reads—uncovering hidden complexity in aging, neurodegeneration, and cancer. See how researchers are using full-length reads to expose novel biology and drive deeper discoveries, all through an accessible, end-to-end workflow.